G110

Guanabenz acetate salt

α2 adrenoceptor agonist, powder

• Synonim(y): 1-(2,6-Dichlorobenzylideneamino)guanidine acetate salt, WY-8678
• Wzór empiryczny (zapis Hilla): C₈H₈Cl₂N₄ · C₂H₄O₂
• Numer CAS: 23256-50-0
• Masa cząsteczkowa: 291.13
• NACRES: NA.77
• PubChem Substance ID: 24277775
• UNSPSC Code: 12352200
• EC Number: 245-534-7
• MDL number: MFCD00153801
• Form: powder

Właściwości

• Nazwa produktu: Guanabenz acetate salt, powder
• form: powder
• Quality Segment: 200
• color: white
• solubility: H₂O: 10 mg/mL, alcohol: 50 mg/mL
• originator: Wyeth
• SMILES string: CC(O)=O.NC(=N)N\N=C\c1c(Cl)cccc1Cl
• InChI: 1S/C8H8Cl2N4.C2H4O2/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12;1-2(3)4/h1-4H,(H4,11,12,14);1H3,(H,3,4)/b13-4+;
• InChI key: MCSPBPXATWBACD-GAYQJXMFSA-N
• Gene Information: human ... ADRA2A(150), ADRA2B(151), ADRA2C(152)

Opis

Biochem/physiol Actions

Centrally acting α₂ adrenoceptor agonist; I₂ imidazoline binding site ligand; antihypertensive.

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the α2-Adrenoceptors and Imidazoline Binding Sites pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Wyeth. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• pcodes: P301 + P310
• Hazard Classifications: Acute Tox. 3 Oral
• Klasa składowania: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Faceshields, Gloves